Kodiak Sciences Inc. (KOD)
KOD price $87.49 -5.48 -5.89%
- Ticker
- KOD
- Price
- $87.49
- Change
- -5.48 -5.89%
- Market cap
- $5.50B
- P/E
- -22.19
- Forward P/E
- 15.03
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 35
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses…